A Study of Atezolizumab and Bevacizumab in Hepatocellular Carcinoma
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Howard S Hochster, DO, MPH
Rutgers Cancer Institute of New Jersey
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
7 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of Illinois Cancer Center
Chicago, Illinois, United States
- Indiana University Melvin and Bren Simon Comprehensive Cancer Center
Indianapolis, Indiana, United States
- University of Nebraska Medical Center
Omaha, Nebraska, United States
- Rutgers Cancer Institute of New Jersey
New Brunswick, New Jersey, United States
- New York University Clinical Cancer Center
New York, New York, United States
- Dhr Health Institute for Research and Development
Edinburg, Texas, United States
- Univeristy of Wisconsin
Madison, Wisconsin, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 22 Mar 2021
- Primary completion
- 19 Jun 2024
- Completion
- 15 Oct 2024
- Last update posted
- 16 Jun 2026
- Registered enrollment
- 6
- Registry id
- NCT04829383
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.